April Semilla

April Semilla is a principal consultant with the life sciences team at IHS Markit and provides actionable insights for clients across the life sciences industry with a special focus on where the industry intersects with finance, energy and climate change. Her key focus areas include: supporting client investment decisions in pipeline assets, devices or new service offerings, pharmaceutical market entry, pricing and reimbursement strategy, health policy impact and health workforce analysis. She previously supported the United States federal government agencies such as the Health Resources and Services Administration (HRSA) and the Centers for Disease Control and Prevention (CDC), the Ministry of Health in Zambia, health systems, associations, top 10 pharmaceutical and life sciences companies, and various Fortune 500 companies. She has conducted commercial due diligence on municipal bond issue processes for advanced medical facilities. She also has expertise in creating bespoke health impact assessment models that report the impacts of environmental or policy changes on health outcomes. Ms. Semilla holds a Master's Degree in Health Policy and Clinical Studies from Dartmouth College and is currently based in New York.